MDRX

Veradigm Inc.

MDRX, USA

Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle services and coding services; electronic health records solutions, which include eprescribe with EPCS, EHR software, veradigm EHR, and practice fusion EHR; and patient engagement platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as veradigm connect, veradigm app expo, and diagnostic ordering and resulting network; life sciences, health plans and payers, and providers; and veradigm eprescribe enterprise. In addition, the company offers risk adjustment solutions, such as health equity analytics, risk adjustment analytics, risk mitigator, comprehensive submissions, and utilization analytics; quality analytics, risk adjustment, and quality management; data exchange and coding solutions, including echart courier, echart coder, and echart integration and analytics; clinical data registries for physicians and veradigm payer insights; provider engagement solutions; care gap alerting, gap closure services, and veradigm payerpath solutions. Further, it provides real world data solutions, such as NLP-enriched EHR data solutions, and clinical data registries; real world evidence and real-world evidence analytics platform; and digital health media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.

https://veradigm.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
MDRX
stock
MDRX

Veradigm (NASDAQ:MDRX) Shares Cross Above 200 Day Moving Average – Here’s Why Defense World

Read more →
MDRX
stock
MDRX

Veradigm (NASDAQ:MDRX) Shares Cross Above 200 Day Moving Average - Here's Why MarketBeat

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2024-12-31)

Rating:

BUY

Target Price:

$5.8333

Analyst Picks

Strong Buy

1

Buy

0

Hold

2

Sell

0

Strong Sell

0

Finn Analysis

(Last Updated 2024-12-31)

Health Score

Investors

* Institutions hold a combined 2.82% of the total shares of Veradigm Inc.

1.

Vanguard Explorer Value Inv

(0.6741%)

since

2025/06/30

2.

BlackRock Credit Strategies Instl

(0.54%)

since

2025/06/30

3.

Hartford Small Cap Value Y

(0.4157%)

since

2025/07/31

4.

abrdn Healthcare Opportunities

(0.3114%)

since

2025/07/31

5.

NYLI VP Wellington Small Cap Initial

(0.2772%)

since

2025/07/31

6.

Royce Small-Cap Trust

(0.1417%)

since

2025/06/30

7.

Adirondack Small Cap

(0.0852%)

since

2025/06/30

8.

abrdn World Healthcare

(0.0832%)

since

2025/07/31

9.

Wellington Sm Cap Value Opportunities

(0.0564%)

since

2025/03/31

10.

Wellington CIF II Global Equities

(0.0564%)

since

2025/03/31

11.

BlackRock Global Equity Mkt Netrl Instl

(0.0493%)

since

2025/07/31

13.

Northern Small Cap Core I

(0.0236%)

since

2025/06/30

14.

NT Col Quality SC Val Fd- NL - 3

(0.0175%)

since

2025/03/31

15.

NT Quality Small Cap Core

(0.0128%)

since

2025/06/30

16.

NT Quality SCC US Fund - L

(0.0128%)

since

2025/06/30

17.

FNY Investment Advisers, LLC

(0.012%)

since

2025/06/30

18.

Principal Global Multi-Strategy Instl

(0.0068%)

since

2025/07/31

19.

Wellington Hedged Alpha Opportunities

(0.0068%)

since

2025/06/30

20.

Acclivity Small Cap Value I

(0.0037%)

since

2025/06/30

21.

Humankind US Stock ETF

(0.0024%)

since

2025/08/29

22.

Evli Equity Factor Global IA

(0.001%)

since

2025/08/31

23.

Huntington National Bank

(0%)

since

2025/06/30

24.

Nisa Investment Advisors, L.L.C.

(0%)

since

2025/03/31

26.

Sterling Capital Management LLC

(0%)

since

2025/06/30

27.

Virginia Retirement Systems Et AL

(0%)

since

2025/03/31

28.

GAMMA Investing LLC

(0%)

since

2025/03/31

29.

Kennedy Capital Management Inc

(0%)

since

2025/03/31

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

0.08

Latest Release

Date

2025-09-30

EPS Actual

0

EPS Estimate

0.045

EPS Difference

-0.045

Surprise Percent

-100%

Investing Fit Scorecard

(Last Updated 2024-12-31)

Deep Value
Weak Deep Value(0)
Defensive
Cyclical / Risky(3)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
No Clear Moat(1)
GARP
Not Attractive for GARP(0)
Growth
Weak Growth Prospect(0)
Momentum
No Momentum(3)
Net Net
Not Undervalued (Net-Net)(0)
Quality
Low Quality Business(0)
Value
Overpriced(0)

Income Statement

(Last Updated 2024-12-31)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2024-12-31)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2024-12-31)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.